Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma (Q39262129)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma |
scientific article |
Statements
1 reference
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma (English)
1 reference
Leonard C Edelstein
1 reference
Sophia Micheva-Viteva
1 reference
Bradley D Phelan
1 reference
Joseph P Dougherty
1 reference
1 September 2009
1 reference
1 reference
25
1 reference
9
1 reference
883-887
1 reference
Identifiers
1 reference
1 reference
1 reference